Researchers have further demonstrated that p53 suppresses breast cancer cell invasion and dissemination by activating miR-30a expression, which subsequently inhibits the EMT-related transcription factor ZEB2 (di Gennaro et al., 2018). This evidence concerns the gene TP53 and breast cancer.